Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study.
Banniettis N, Horn M, Sadarangani M, Patel SM, Greenberg D, Oberdorfer P, Klein NP, Rupp R, Dagan R, Richmond P, Lumley J, Zhou W, Shi Y, Tamms G, Feemster K, Lupinacci R, Musey L, Bickham K; V114-031 (PNEU-LINK) study group. Banniettis N, et al. Among authors: sadarangani m. Pediatrics. 2023 Jul 1;152(1):e2022060428. doi: 10.1542/peds.2022-060428. Pediatrics. 2023. PMID: 37309607 Clinical Trial.
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.
Nolan T, Bhusal C, Beran J, Bloch M, Cetin BS, Dinleyici EC, Dražan D, Kokko S, Koski S, Laajalahti O, Langley JM, Rämet M, Richmond PC, Silas P, Tapiero B, Tiong F, Tipton M, Ukkonen B, Ulukol B, Lattanzi M, Trapani M, Willemsen A, Toneatto D; QUINTET study group. Nolan T, et al. Open Forum Infect Dis. 2024 Oct 30;11(11):ofae638. doi: 10.1093/ofid/ofae638. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39582508 Free PMC article. Clinical Trial.
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.
Nolan T, Bhusal C, Beran J, Bloch M, Cetin BS, Dinleyici EC, Dražan D, Kokko S, Koski S, Laajalahti O, Langley JM, Rämet M, Richmond PC, Silas P, Tapiero B, Tiong F, Tipton M, Ukkonen B, Ulukol B, Lattanzi M, Trapani M, Willemsen A, Toneatto D; QUINTET study group. Nolan T, et al. Lancet Infect Dis. 2024 Dec 5:S1473-3099(24)00667-4. doi: 10.1016/S1473-3099(24)00667-4. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39647494
Antiviral Use in Canadian Children Hospitalized for Influenza.
Mehta K, Morris SK, Bettinger JA, Vaudry W, Jadavji T, Halperin SA, Bancej C, Sadarangani M, Dendukuri N, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Mehta K, et al. Among authors: sadarangani m. Pediatrics. 2021 Oct;148(4):e2020049672. doi: 10.1542/peds.2020-049672. Epub 2021 Sep 21. Pediatrics. 2021. PMID: 34548379
Assessment of infant position and timing of stylet removal to improve lumbar puncture success in neonates (NeoCLEAR): an open-label, 2 × 2 factorial, randomised, controlled trial.
Marshall ASJ, Scrivens A, Bell JL, Linsell L, Hardy P, Yong J, Williams R, Adams E, Sadarangani M, Juszczak E, Roehr CC; NeoCLEAR Collaborative Group. Marshall ASJ, et al. Among authors: sadarangani m. Lancet Child Adolesc Health. 2023 Feb;7(2):91-100. doi: 10.1016/S2352-4642(22)00343-1. Epub 2022 Nov 29. Lancet Child Adolesc Health. 2023. PMID: 36460015 Free article. Clinical Trial.
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K. Nakabembe E, et al. Among authors: sadarangani m. Lancet Glob Health. 2025 Jan;13(1):e81-e97. doi: 10.1016/S2214-109X(24)00409-1. Lancet Glob Health. 2025. PMID: 39706666 Free PMC article. Clinical Trial.
mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study.
Soe P, Vanderkooi OG, Sadarangani M, Naus M, Muller MP, Kellner JD, Top KA, Wong H, Isenor JE, Marty K, Shulha HP, De Serres G, Valiquette L, McGeer A, Bettinger JA. Soe P, et al. Among authors: sadarangani m. Lancet Reg Health Am. 2024 Nov 27;40:100949. doi: 10.1016/j.lana.2024.100949. eCollection 2024 Dec. Lancet Reg Health Am. 2024. PMID: 39659558 Free PMC article.
Burden of infant group B Streptococcus disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort study.
Fakhraei R, Fell DB, El-Chaâr D, Thampi N, Sander B, Brown KA, Crowcroft N, Bolotin S, Barrett J, Darling EK, Fittipaldi N, Lamagni T, McGeer A, Murti M, Sadarangani M, Schwartz KL, Yasseen A, Tunis M, Petrcich W, Wilson K. Fakhraei R, et al. Among authors: sadarangani m. Lancet Reg Health Am. 2024 Oct 24;39:100914. doi: 10.1016/j.lana.2024.100914. eCollection 2024 Nov. Lancet Reg Health Am. 2024. PMID: 39507368 Free PMC article.
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.
Top KA, Shulha HP, Muller MP, Valiquette L, Vanderkooi OG, Kellner JD, Sadarangani M, Irvine MA, McGeer A, Isenor JE, Marty K, Soe P, De Serres G, Bettinger JA; Canadian Immunization Research Network Investigators. Top KA, et al. Among authors: sadarangani m. Vaccine. 2024 Dec 2;42(26):126445. doi: 10.1016/j.vaccine.2024.126445. Epub 2024 Oct 16. Vaccine. 2024. PMID: 39413493 Free article.
228 results